Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Does Natalizumab Therapy Benefit Patients With Multiple Sclerosis?
Type I interferon in human autoimmunity.
Decision-making impairment in patients with multiple sclerosis: a case-control study.
Role of Glia in Stress-Induced Enhancement and Impairment of Memory.
Correction: The Nuclear IκB Family Protein IκBNS Influences the Susceptibility to Experimental Autoimmune Encephalomyelitis in a Murine Model.
Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia.
Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - A pilot study.
Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.
Alemtuzumab and Multiple Sclerosis: Another Note of Caution.
Neuromyelitis optica spectrum disorder in a patient with Kikuchi-Fujimoto disease.
Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol - studies in BV-2 microglia and encephalitogenic T cells.
Importance of Apolipoprotein A-I in Multiple Sclerosis.
A systems pharmacology approach to decipher the mechanism of danggui-shaoyao-san decoction for the treatment of neurodegenerative diseases.
Frequency of myasthenia gravis in multiple sclerosis: Report of five cases from Isfahan, Iran.
[Genome-wide association study as a method for genetic architecture analysis in polygenic diseases (by the example of multiple sclerosis)].
Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma.
Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE.
A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients.
Longitudinally extensive transverse myelitis suspected for isolated Neuro-Behçet: A diagnostic conundrum.
Patient-specific early classification of multivariate observations.
Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
An unusual presentation of X-linked adrenoleukodystrophy.
Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway.
Both endoplasmic reticulum and mitochondrial pathways are involved in oligodendrocyte apoptosis induced by capsular hemorrhage.
Sexual Dysfunction in Male Patients with Multiple Sclerosis: A Need for Counseling!
Pages
« first
‹ previous
…
648
649
650
651
652
653
654
655
656
…
next ›
last »